Ali Mehdi
-
For pharma’s sake, drug regulatory agencies need to cooperate
The pharmaceutical Sector in India is at the crossroads. Having established itself as the world leader in the space of generics—accounting for one-fifth of the global generic export volume (IBEF)—it has begun to take the next leap, and is regarded as an emerging hub of pharmaceutical research and innovation.
-
Healthcare: Narendra Modi govt does well to think of door-to-door screening for cancer, diabetes
The government has done well to think about door-to-door screening for cancer, heart disorders and diabetes given the rise in premature deaths
-
The Indian health challenge : What ails India’s workers
The first step is to admit the health challenges. Only then will we start thinking of ways to address them
-
India need a medical commission at central and state levels; Here’s why
The country is in dire need of both national and state level medical commissions
-
Why chronic diseases crisis in India must be tackled now
We need to prioritise public health allocations and reduce budgetary inefficiencies
-
Making healthcare affordable in India
Much before the Union Budget was unveiled, Indian pharmaceutical and medical device manufacturers were granted significant competitive privileges over their foreign counterparts.
